Fortis Advisors, LLC Bristol Myers Squibb CO Transaction History

Fortis Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $435 - $257,414	-3,350 Reduced 63.06%	1,962 $139,000
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $68,989 - $75,981	-950 Reduced 15.17%	5,312 $409,000
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $174,941 - $203,940	3,262 Added 108.73%	6,262 $390,000
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $177,510 - $207,930	3,000 New	3,000 $178,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortis Advisors, LLC with notifications on news.